vimarsana.com

Latest Breaking News On - Iris bincovich - Page 14 : vimarsana.com

Innocan Pharma Corporation: Innocan Pharma Signs a First Consulting Agreement to Commercialize its Pharmaceutical IP in the Veterinary Field

Herzliya, Israel and Calgary, Alberta (Newsfile Corp. - December 2, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology

Germany
Herzliya
Tel-aviv
Israel
Canada
Stonehaven
New-brunswick
Switzerland
Canadian
Iris-bincovich
Antonio-benitz
Eva-reuter

Innocan Pharma Signs a First Consulting Agreement to Commercialize its Pharmaceutical IP in the Veterinary Field

Innocan Pharma Signs a First Consulting Agreement to Commercialize its Pharmaceutical IP in the Veterinary Field
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Germany
Herzliya
Tel-aviv
Israel
Canada
Stonehaven
New-brunswick
Switzerland
Canadian
Iris-bincovich
Antonio-benitz
Eva-reuter

Innocan Pharma Corporation: Innocan Pharma Reports Q3 2022 Results with 700% Increase in Revenues Compared to Q3 2021

Herzliya, Israel and Calgary, Alberta (Newsfile Corp. - November 29, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pharmaceutical technology

Germany
Herzliya
Tel-aviv
Israel
Canada
Canadian
Iris-bincovich
Eva-reuter
Bi-sky-global-ltd
Company-or-innocan
Alberta-newsfile-corp
Innocan-pharma-corporation

Mr. Givi Topchishvili to Join Innocan Pharma's Advisory Committee

Mr. Givi Topchishvili to Join Innocan Pharma's Advisory Committee
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Germany
Herzliya
Tel-aviv
Israel
Canada
Canadian
Iris-bincovich
Eva-reuter
Innocan-pharma
Bi-sky-global-ltd
Company-or-innocan
Advisory-committee
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.